Some physicians are returning to old-fashioned, solo practices that allow them to spend more time with patients. Pat Loeb spent time with one doctor who's made the switch.
Today's annual report on the fiscal health of the Medicare system is expected to put forth a prognosis so bleak it will trigger the program's first-ever funding warning. And even that probably won't make a difference.
AstraZeneca, which has been struggling to get new drugs to market, is looking to get into the biological medicines game. So it's going to pay $15.6 billion for MedImmune to make it happen.
Drug companies are expected to pump out a record 132 million doses of flu vaccine for next winter — even though there were 20 million doses left over this year.
AOL founder Steve Case has put up $100 million of his own money on the belief that American health consumers are ready for a change. He's launching a website today that aims to give us "better choices, more convenience and more control."
When a seriously depressed person requires an antidepressant, he needs a doctor's permission. If a person wants to buy a gun, he needs only two forms of ID. Commentator Robert Reich has some thoughts about that.
A bill to allow Medicare to negotiate cheaper drug prices failed in the Senate today, as Democrats couldn't muster enough votes to break a Republican filibuster. Helen Palmer reports.
The vaccine is less than 50 percent effective and only has a shelf life of 18 months, but the FDA says it's still worth approving and stockpiling — because in the event of a pandemic, saving some lives will be better than none.
AARP announced health plans for people between 50 and 64 and for those already on Medicare. Economist Glenn Melnick talked with host Tess Vigeland about what the organization for retirees is doing.
Private health insurance is getting to be a big business for America's largest senior lobby. AARP today announced an expanded deal with UnitedHealth. The goal: Double insurance sales to the 50+ crowd.
